Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

Description

This clinical trial aims to determine the effects of a 6-day low-dose methylprednisolone course on pain, nausea, and total opioid consumption in patients undergoing foot and ankle surgeries. The secondary objective of the study is to determine and monitor the effects of the course on complications following surgery and patient-reported outcomes

Conditions

Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury

Talk to us

Study Overview

On this page

Study Details

Study overview

This clinical trial aims to determine the effects of a 6-day low-dose methylprednisolone course on pain, nausea, and total opioid consumption in patients undergoing foot and ankle surgeries. The secondary objective of the study is to determine and monitor the effects of the course on complications following surgery and patient-reported outcomes

Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

Condition
Foot Injuries and Disorders
Intervention / Treatment

-

Contacts and Locations

Atlanta

Emory Musculoskeletal Institute, Emory Orthopaedics & Spine Center, Atlanta, Georgia, United States, 30329

Johns Creek

Emory Sports Medicine Complex and Emory Orthopaedics and Spine Center, Johns Creek, Georgia, United States, 30022

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Concurrent or significant injuries to other bones or organs
  • * Local infections
  • * History of alcohol or medical abuse, including prior opioid abuse
  • * Smoking
  • * History of severe heart disease, renal failure, liver dysfunction, active peptic ulcer disease, diabetes, rheumatoid arthritis, neurological or psychiatric diseases that could influence pain perception
  • * Pre-existing immune suppression
  • * Those deemed possibly non-compliant by the study team and,
  • * All vulnerable populations (those unable to give consent, juveniles, pregnant women, prisoners, cognitively impaired and non-English speaking).

Ages Eligible for Study

18 Years to 95 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Emory University,

Rishin Kadakia, MD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

2026-12